Suppr超能文献

toll 样受体(TLRs):在癌症发病机制中具有新面貌的免疫受体大家族。

Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.

机构信息

Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Immunology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

J Cell Mol Med. 2021 Jan;25(2):639-651. doi: 10.1111/jcmm.16214. Epub 2020 Dec 18.

Abstract

In the dark path of tumorigenesis, the more carefully the cancer biology is studied, the more brilliant answers could be given to the countless questions about its orchestrating derivers. The identification of the correlation between Toll-like receptors (TLRs) and different processes involved in carcinogenesis was one of the single points of blinding light highlighting the interconnection between the immune system and cancer. TLRs are a wide family of single-pass membrane-spanning receptors that have developed through the evolution to recognize the structurally conserved molecules derived from microorganisms or damaged cells. But this is not everything about these receptors as they could orchestrate several downstream signalling pathways leading to the formation or suppression of cancer cells. The present review is tempted to provide a concise schematic about the biology and the characters of TLRs and also summarize the major findings of the regulatory role of TLRs and their associated signalling in the pathogenesis of human cancers.

摘要

在肿瘤发生的黑暗道路上,对癌症生物学的研究越深入,就越能对无数关于其调控机制的问题给出精彩的答案。 Toll 样受体 (TLRs) 与癌发生过程中涉及的不同过程之间的相关性的鉴定是揭示免疫系统和癌症之间相互联系的单点耀眼光芒之一。TLRs 是一组广泛的单次跨膜跨膜受体家族,它们通过进化发展起来,以识别来自微生物或受损细胞的结构保守分子。但这并不是这些受体的全部,因为它们可以协调几个下游信号通路,导致癌细胞的形成或抑制。本综述试图提供关于 TLRs 的生物学和特性的简明示意图,并总结 TLRs 的调节作用及其相关信号在人类癌症发病机制中的主要发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cda/7812258/47e04be94200/JCMM-25-639-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验